Loading
XT
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) Stock: price and insider trades · Canada
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.): what insiders have been doing
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) is a listed company. Filings by its managers are published through SEDI. No insider at XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) has published a filing in the past twelve months. The most recent one dates from 3 March 2021.
Since 2018, the database holds 62 purchases and no sales by insiders of the company.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
78
Thresholds
n/a
Buy Volume
€87,408
62 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 3 March 2021
Declarations78 total
150,000 shares@ CA$0.2573.5% of flowCommon SharesTSXSEDI:3691920
357,142 shares@ CA$0.2594.7% of flowCommon SharesTSXSEDI:3688924
200,000 shares@ CA$0.2539.0% of flowCommon SharesTSXSEDI:3688915
260,000 shares@ CA$0.2533.6% of flowCommon SharesTSXSEDI:3677370
100,000 shares@ CA$0.2532.9% of flowCommon SharesTSXSEDI:3677359
5,000 shares@ CA$0.18Common SharesTSXSEDI:3599471
Canonical exit: 3 Dec 2020 (T+90)
5,000 shares@ CA$0.18Common SharesTSXSEDI:3599473
Canonical exit: 7 Dec 2020 (T+90)
Common SharesTSXSEDI:3595051
65,000 shares@ CA$0.2212.4% of flowCommon SharesTSXSEDI:3590861
Canonical exit: 16 Nov 2020 (T+90)
3,500 shares@ CA$0.160.5% of flowCommon SharesTSXSEDI:3575208
Canonical exit: 7 Oct 2020 (T+90)
5,000 shares@ CA$0.140.3% of flowCommon SharesTSXSEDI:3566098
Canonical exit: 17 Sept 2020 (T+90)
10,000 shares@ CA$0.150.6% of flowCommon SharesTSXSEDI:3566097
Canonical exit: 16 Sept 2020 (T+90)
5,000 shares@ CA$0.140.3% of flowCommon SharesTSXSEDI:3562948
Canonical exit: 9 Sept 2020 (T+90)
1,000 shares@ CA$0.140.1% of flowCommon SharesTSXSEDI:3559346
Canonical exit: 31 Aug 2020 (T+90)
9,000 shares@ CA$0.150.5% of flowCommon SharesTSXSEDI:3559347
Canonical exit: 31 Aug 2020 (T+90)
10,000 shares@ CA$0.150.6% of flowCommon SharesTSXSEDI:3559348
Canonical exit: 31 Aug 2020 (T+90)
5,000 shares@ CA$0.150.3% of flowCommon SharesTSXSEDI:3559349
Canonical exit: 1 Sept 2020 (T+90)
357,143 shares@ CA$0.1421.2% of flowCommon SharesTSXSEDI:3512192
150,000 shares@ CA$0.1422.4% of flowCommon SharesTSXSEDI:3512189
5,500 shares@ CA$0.1526.8% of flowCommon SharesTSXSEDI:3454002
Canonical exit: 9 Feb 2020 (T+90)
12,500 shares@ CA$0.1873.2% of flowCommon SharesTSXSEDI:3443251
Canonical exit: 28 Jan 2020 (T+90)
5,000 shares@ CA$0.1427.3% of flowCommon SharesTSXSEDI:3419838
Canonical exit: 20 Nov 2019 (T+90)
5,000 shares@ CA$0.1733.1% of flowCommon SharesTSXSEDI:3411581
Canonical exit: 11 Nov 2019 (T+90)
5,000 shares@ CA$0.1912.6% of flowCommon SharesTSXSEDI:3384950
Canonical exit: 11 Sept 2019 (T+90)
10,000 shares@ CA$0.1928.9% of flowCommon SharesTSXSEDI:3373201
Canonical exit: 21 Aug 2019 (T+90)
25 of 78 declarations
About XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
XORTX Therapeutics Inc. is a biotechnology company focused on developing treatments for kidney diseases. Formerly known as APAC Resources Inc., it is listed on the XTSE.
